A highly sensitive quantitative bioassay for human granulocyte-macrophage colony-stimulating factor

Area of Science:

• Hematology
• Cell Biology
• Biotechnology

Background:

• Granulocyte-macrophage colony-stimulating factor (GM-CSF) is crucial for myeloid cell development.
• Accurate quantification of GM-CSF is essential for understanding various physiological and pathological processes.
• Existing bioassays may lack specificity or sensitivity for detecting low GM-CSF concentrations.

Purpose of the Study:

• To develop a highly specific and sensitive bioassay for quantifying bioactive human GM-CSF.
• To establish a novel cell line dependent on GM-CSF for bioassay development.
• To validate the assay's performance using diverse biological samples.

Main Methods:

• Established a human myeloid cell line (GM/SO) dependent on GM-CSF.
• Utilized MTT assay to measure formazan production by GM-CSF-stimulated cells.
• Quantified GM-CSF in human sera, cell line conditioned media, and peripheral blood mononuclear cells.

Main Results:

• Developed a sensitive bioassay for human GM-CSF with a detection limit as low as 0.1 U/ml.
• Successfully quantified GM-CSF in various biological matrices, including serum and conditioned media.
• Demonstrated the assay's specificity through its reliance on GM-CSF-dependent cell proliferation.

Conclusions:

• The novel GM/SO cell line enables a specific and sensitive bioassay for human GM-CSF.
• This bioassay is effective for quantifying GM-CSF levels in diverse biological samples.
• The assay provides a valuable tool for research and clinical applications involving GM-CSF.